WEST LAFAYETTE, Ind. — Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will ...
Researchers have conducted the largest-ever genetic analysis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a typically lifelong condition that affects people's ability to exert ...
People diagnosed with ME/chronic fatigue syndrome (CFS) have significant differences in their DNA compared to those without the condition, according to a “groundbreaking” new study. Scientists said ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback